Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 23,480 shares at $28.44 ($657K) on 2016-05-03, disclosed to the SEC on 2016-05-04.
Open-market sale of $657k MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.80 | 16,338 | $454K | 69.1% |
| 2 | $28.44 | 7,142 | $203K | 30.9% |
| Total | $27.99 avg | 23,480 | $657K | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |